A Phase I study of LJPC-401 in healthy adult volunteers

Completed

• Conditions: Thalassemia; Sickle Cell Disease; Hemochromatosis; Myelodysplasia; Blood - Haematological diseases

• Registration Number: ACTRN12616000132448
• Lead Sponsor: a Jolla Pharmaceutical Company

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-02-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Normal, healthy volunteers, negative drug and alcohol tests, BMI 18-32 inclusive

Exclusion Criteria

Blood pressure less than 90/60 or greater than 160/100, limited alcohol and tobacco use, infection or other serious underlying medical condition

Study & Design

• Study Type: Interventional
• Study Design: Not specified